Nr 546 week 8 alzheimers Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Nr 546 week 8 alzheimers? On this page you'll find 11 study documents about Nr 546 week 8 alzheimers.
All 11 results
Sort by
-
NR 546 WEEK 8 ALZHEIMER’S DISEASE (AD) EXAM QUIZ QUESTIONS WITH DETAILED CORRECT ANSWERS 2025| VERIFIED ANSWERS
- Exam (elaborations) • 8 pages • 2024
-
- $17.99
- + learn more
NR 546 WEEK 8 ALZHEIMER’S DISEASE 
(AD) EXAM QUIZ QUESTIONS WITH 
DETAILED CORRECT ANSWERS 2025| 
VERIFIED ANSWERS
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $11.49
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $12.99
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $10.99
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 WEEK 8 - ALZHEIMER'S DISEASE 2024 EXAM QUIZ QUESTIONS WITH DETAILED CORRECT ANSWERS | VERIFIED ANSWERS
- Exam (elaborations) • 16 pages • 2024
-
Available in package deal
-
- $19.99
- + learn more
NR 546 WEEK 8 2024 EXAM QUIZ 
QUESTIONS WITH DETAILED 
CORRECT ANSWERS | VERIFIED 
ANSWERS
Get paid weekly? You can!
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $11.49
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme ...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $12.49
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme ...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $13.99
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class 
FDA Indication (include stages ) 
Neurotransmitters Affected/Mechanism of Action 
Target Symptoms 
Short-acting, intermediate-acting, or long-acting. 
Duration of Action and Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education Instructions 
Donepezil (Aricept) 
Alzheimer’s disease – mild, moderate, and severe 
Acetylcholine enzyme inhibi...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+ Drug Name and Class FDA Indication (include stages ) Neurotransmitters Affected/Mechanism of Action Target Symptoms Short-acting, intermediate-acting, or
- Exam (elaborations) • 7 pages • 2024
-
- $10.99
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholin...
-
WEEK 8 NR 546 QUESTIONS WITH CORRECT ANSWERS 2024.
- Exam (elaborations) • 5 pages • 2024
-
- $10.99
- + learn more
WEEK 8 NR 546 QUESTIONS WITH CORRECT ANSWERS 2024.
That summary you just bought made someone very happy. Also get paid weekly? Sell your study resources on Stuvia! Discover all about earning on Stuvia